Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer

BACKGROUND: Single agent immune checkpoint inhibitors (ICIs) improve survival outcomes compared to chemotherapy for advanced non‐small cell lung cancer (NSCLC), but treatment efficacy widely varies. The combination of ICIs with chemotherapy has shown promising efficacy over chemotherapy alone; howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Chih‐Hsi Scott, Wang, Chin‐Chou, Huang, Yu‐Chen, Pavlidis, Stelios, Liu, Chien‐Ying, Ko, How‐Wen, Chung, Fu‐Tsai, Lin, Tin‐Yu, Wang, Chih‐Liang, Guo, Yi‐Ke, Yang, Cheng‐Ta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501017/
https://www.ncbi.nlm.nih.gov/pubmed/30950239
http://dx.doi.org/10.1111/1759-7714.13057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501017/
https://www.ncbi.nlm.nih.gov/pubmed/30950239
http://dx.doi.org/10.1111/1759-7714.13057

Ejemplares similares